Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Investing in Safety: Laxxon Medical's QR Code Technology and the Fight Against Counterfeit Drugs
Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024
The Controlled Release Drug Delivery Market
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
Revolutionizing Parkinson's Treatment: How Laxxon's Extended-Release Levodopa Improves Quality of Life
The Potential of 3D Screen Printing to Combat Counterfeit Medication
Digital Tools In the Healthcare Industry: Addressing Counterfeit Medicine and Safety
Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference
Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs Within Pharmaceutical Dosage Forms
Breaking Down Obesity: Understanding Its Effects and Navigating Treatment Options
3D Screen Printing Offers Unprecedented Anticounterfeiting Strategies for Oral Solid Dosage Forms Feasible for Large Scale Production
The Role of Patent Extensions in Healthcare: Balancing Innovation and Access
The Impact of Technology on Pharmaceutical Research: Speed, Efficiency, and Accuracy
What Is the FDA 505b2 Pathway?
Revolutionizing Pharma: 3D Screen Printing and Smart Technologies Shaping the Future of Medicine
Advancing medication with the right DDS: Immediate and delayed release
Laxxon Medical to Participate in 26th Annual Needham Growth Conference
Legally Protecting Inventions and Innovations Related to the Medical Field